Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Crixivan (Indinavir Sulfate) Capsules, Merck & Co. NDA 20-685/S57 6/9/03 7/8/03 7/8/03 Crixivan (Indinavir Sulfate) Capsules, Merck & Co. NDA 20-685/S55 9/19/02 9/24/02 9/20/02 Crixivan (Indinavir Sulfate) Capsules, 100, 200, 333 & 400 mg Merck Research NDA 20-685/ S050, S053 & S056 6/20/02 6/24/02 6/21/02 Crixivan (Indinavir Sulfate) Capsules, 200 mg, 333 mg, and 400 mg Merck NDA 20-685/ S050 & S053 1/25/02 2/4/02 Crixivan (Indinavir Sulfate) Capsules, 200 mg, 333 mg, and 400 mg Merck NDA 20-685/ S041 3/21/01 4/25/01 4/25/03 Crixivan (Indinavir Sulfate) Merck NDA 020-685/ S022 Crixivan (Indinavir Sulfate) Capsules, Merck & Co. Inc. Crixivan (indinavir sulfate) capsules, Merck & Co., Inc. | Crixivan (indinavir sulfate) capsules, Merck & Co., Labeling Revision | Crixivan (indinavir sulfate) capsules, Merck & Co., Labeling Revision | Crixivan (indinavir sulfate) capsule, Merck and Co., Labeling Revision | Crixivan (indinavir sulfate) Capsules, Merck & Co., Labeling Revision | Crixivan (indinavir sulfate) Capsules, Merck & Co., Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com